The achievement of that goal in India, which ranks third in obesity numbers after the US and China, will shatter the record ...

MSD has received US Food and Drug Administration (FDA) approval for its anti-programmed death receptor-1 (PD-1) therapy, Keytruda (pembrolizumab), for adults with resectable locally advanced head and ...

Pfizer has terminated a Phase II study of its CD47 immune checkpoint inhibitor, maplirpacept, due to low recruitment. In an ...

On 16 March 2024, New Delhi Police arrested Neeraj Chauhan and others for selling fake anti-cancer drugs to patients at a ...

It boasts more than 80 programs in phase 2 or phase 3 studies. Even with a 25% success rate for these, that should translate ...

Johnson & Johnson is an impeccable dividend stock with a streak of 63 consecutive dividend raises. The company's long history of payout increases is another piece of evidence that points to the ...

From cancer immunotherapy to diabetes and weight loss breakthroughs, 2025’s top-selling drugs highlight how pharmaceutical ...

The UK’s medical research charity LifeArc has received a windfall of nearly $1.3 billion after selling a portion of its royalty interest in Merck & Co’s blockbuster cancer drug Keytruda to a ...

From our seniors and working families to our job-creating manufacturers, the Lehigh Valley relies on stable access to imported medicines and ingredients. Tariffs would put lives, livelihoods, and ...

Its Herceptin biosimilar nearing launch, Celltrion begins work on Keytruda copySouth Korea’s Celltrion has started work on a biosimilar version of pembrolizumab, Merck & Co’s blockbuster ...

As drug development increasingly targets multiple indications, pharma companies must make strategic branding ...

The Medical - Generic Drugs industry comprises companies that develop and market chemically/biologically identical versions of a brand-name drug once patents ... of Merck’s blockbuster oncology drug ...